Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 8/20 | 0.48 |
| ▸ | CALCR | P30988 | 4/20 | 0.47 |
| ▸ | VIPR2 | P41587 | 4/20 | 0.44 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.44 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29856056 | 0.89 | CALCR (0.52) | BACE1CALCRVIPR2VIPR1CRHR1 | |
| SCHEMBL30904413 | 0.86 | BACE1 (0.45) | BACE1CALCRVIPR2VIPR1CRHR1 | |
| SCHEMBL30668921 | 0.86 | OPRK1 (0.48) | BACE1CTSD | |
| SCHEMBL31182644 | 0.86 | CALCR (0.54) | BACE1CALCRVIPR2VIPR1CRHR1 | |
| SCHEMBL29833166 | 0.86 | CALCR (0.38) | CALCRIL23R | |
| SCHEMBL30168736 | 0.85 | BACE1 (0.53) | BACE1CALCRVIPR2VIPR1CTSD | |
| SCHEMBL30168783 | 0.85 | BACE1 (0.53) | BACE1CALCRVIPR2VIPR1CTSD | |
| SCHEMBL29682077 | 0.85 | CALCR (0.40) | CALCRIL23R | |
| SCHEMBL29449897 | 0.85 | BACE1 (0.47) | BACE1CTSD | |
| SCHEMBL30819418 | 0.84 | UTS2R (0.43) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116712528-A | Nereid active peptide composition and application thereof in preparation of antitumor drugs | 滨州医学院 | 2023-09-08 | — | — | CN | claimed |
| CN-116712528-A | Nereid active peptide composition and application thereof in preparation of antitumor drugs | 滨州医学院 | 2023-09-08 | — | — | CN | disclosed |